Discover

News & Info

Quote List Quote List

Johnson & Johnson(JNJ.US)

Trending

Earning Release Date

FY2026 Q1 Earning Release 2026.04.14 (EST) Pre-Market

Event Tracking

Apr1

Johnson & Johnson's New Drug JNJ-88549968 Approved for Clinical Trials to Treat Myeloproliferative Neoplasms

13:13

Mar30

Royalty Pharma and Johnson & Johnson Reach $500 Million Joint Financing Agreement to Develop Autoimmune Disease Therapy

11:19

Johnson & Johnson Receives Regulatory Approval for Darzalex Self-Administration

09:30

Mar28

Johnson & Johnson Announces Positive Phase 3 Clinical Trial Results for ICOTYDE for Psoriasis

14:00

Orser Capital Management LLC Increases Johnson & Johnson Stock Holdings in Q4

09:23

Mar27

Johnson & Johnson's DARZALEX Subcutaneous Administration Approved in Europe

12:34

Schedules & Filings

Schedules

Filings

Apr14

Earning Release(EST)

FY2026 Q1 Earning Release

Mar10

Distribution Plan(EST)

Cash dividend 1.3 USD

Feb24

Distribution Plan(EST)

Cash dividend 1.3 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More